NCT04562181

Brief Summary

The first objective of this work is to compare the performances of three electroencephalogram based indices, the qCON index, the qNOX index and the bispectral index (BIS), in patients receiving gastrointestinal surgery during first postoperative night. Secondly, their behaviors under general anesthesia are also pointed out. The qCON and qNOX indices are implemented in an Angel 6000 monitor (WellHealth Medical Co Ltd., Shenzhen, China), and BIS indices are recorded in a BIS monitor (Aspect Medical Systems, Norwood, MA, USA). Data will be obtained from 30 patients scheduled for selective surgery undergoing general anesthesia with a combination of propofol, sufentanil and cis-atracurium in the first Hospital of China Medical University. The values of qCON, qNOX and BIS were statistically compared. The qCON, qNOX indices are recorded together with BIS during the whole operation period (Awake- Anesthesia-Recovery stages), as well as during the first night postoperatively (from 8:00pm to 06:00am). The values of qCON, qNOX and BIS were statistically compared. The Consistency evaluation will be conducted between qCON/qNOX and BIS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 14, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 24, 2020

Completed
6 days until next milestone

Study Start

First participant enrolled

September 30, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2021

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 5, 2021

Completed
Last Updated

November 9, 2021

Status Verified

November 1, 2021

Enrollment Period

1 year

First QC Date

September 14, 2020

Last Update Submit

November 5, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • qCON/qNOX indices of the first postoperative night

    This study will characterise the qCON/qNOX index data in 30 patients during first postoperative night

    on the first postoperative night

Secondary Outcomes (1)

  • qCON/qNOX indices data during operation

    from the beginning to the end of surgery

Study Arms (1)

Interventions

EXPERIMENTAL

Anesthesia will be induced with bolus infusion using propofol, sufentanil and cis-atracurium intravenously. The patients will be intubated subsequently. TOF (T4/T1) will be calculated continuously using muscle relaxation monitoring. Anesthesia are maintained with a combination of sevoflurane, propofol, sufentanil and cis-atracurium. Anti-emetic and opioids will be routinely administrated prior to abdominal closure. Neostigmine will be administrated for reversing the residual neuromuscular blockade after the patient get his breath. Tracheal extubating is indicated by a TOF value above 70% in addition to other physical signs.

Other: Bispectral index and qCON/qNOX monitoring

Interventions

This study will characterise the bispectral index data and qCON/qNOX index data in 30 patients during the operation and first postoperative night

Interventions

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ethnic Chinese;
  • Age: from 18 to 80 years old;
  • Hospitalized patients

You may not qualify if:

  • Cognitive difficulties
  • Mental diseases
  • Without an informed consent
  • Inability to cooperate with the researcher's requirements
  • Deprivation of the human right by an administrative or juridical entity
  • Ongoing participation or participation in another study within 1 month
  • Night surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wen-fei Tan

Shenyang, Liaoning, 110001, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 14, 2020

First Posted

September 24, 2020

Study Start

September 30, 2020

Primary Completion

October 10, 2021

Study Completion

November 5, 2021

Last Updated

November 9, 2021

Record last verified: 2021-11

Locations